Illinois

Back to map

Showing 1-10 of 15 grants

Title Institution Researcher Program Duration Total Award Amount
Evaluating the Initial Efficacy, Acceptability, and Feasibility of BFST-DT, an Intervention for Improving Transition Readiness for Adolescents and Emerging Adults with Type 1 Diabetes Ann & Robert H. Lurie Children’s Hospital of Chicago Jaclyn Papadakis Improving Lives 01-May-2023 to 30-April-2027 $396,471.68
A hybrid effectiveness implementation trial of an intervention to reduce diabetes-specific emotional distress. Ann & Robert H. Lurie Children’s Hospital of Chicago Jill Weissberg-Benchell Improving Lives 01-September-2024 to 31-August-2029 $1,936,551.00
Risk and Protective Factors for Optimal Health Outcomes in Children with Type 1 Diabetes (T1D) and their Parents Ann & Robert H. Lurie Children’s Hospital of Chicago Jillian Merrick Transportfolio 01-September-2023 to 31-August-2025 $129,046.51
Mitigating Diabetic Ketoacidosis Risk in Adjunctive Therapy (MDKARAT) Illinois Institute of Technology Mudassir Rashid Improving Lives 01-April-2022 to 31-March-2025 $255,709.80
A New Preparation of the Intact Eye for Measurements of Retinal Dysfunction in Acute Hyperglycemia and Early Diabetes Northwestern University Gregory Schwartz Improving Lives 01-October-2023 to 30-September-2025 $406,927.40
Assessment of a Tolerogenic Nanoparticle in a Humanized Mouse Islet Transplantation Model Northwestern University Jacqueline Burke Cures 01-April-2024 to 31-March-2026 $499,746.76
Validation of a Tolerogenic Nanotherapy for Islet Transplantation in a Non-Human Primate Model Northwestern University Jacqueline Burke Cures 01-July-2023 to 30-June-2026 $998,275.64
PLGA nanoparticle treatment-induced antigen-specific CD4+ regulatory T cell control of effector CD8+ T cell responses in a model of type 1 diabetes Northwestern University Stephen Miller Cures 01-September-2025 to 31-August-2028 $659,990.00
Dissecting HLA Mechanisms in T1D, SLE, and MS Through High-Throughput Self-Antigen Profiling The University of Chicago Aly Khan Cures 01-September-2025 to 31-August-2026 $150,000.00
Investigating the role of integrated stress response in type 1 diabetes The University of Chicago Charanya Muralidharan Cures 01-March-2023 to 28-February-2026 $209,066.00